X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE BIOCON LTD TTK HEALTHCARE/
BIOCON LTD
 
P/E (TTM) x 50.7 76.7 66.1% View Chart
P/BV x 9.3 7.2 129.4% View Chart
Dividend Yield % 0.3 0.2 181.1%  

Financials

 TTK HEALTHCARE   BIOCON LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
BIOCON LTD
Mar-17
TTK HEALTHCARE/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs6631,162 57.1%   
Low Rs399483 82.7%   
Sales per share (Unadj.) Rs535.6194.6 275.3%  
Earnings per share (Unadj.) Rs15.934.4 46.3%  
Cash flow per share (Unadj.) Rs20.048.3 41.5%  
Dividends per share (Unadj.) Rs4.001.00 400.0%  
Dividend yield (eoy) %0.80.1 619.1%  
Book value per share (Unadj.) Rs137.6241.9 56.9%  
Shares outstanding (eoy) m7.77200.00 3.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.2 23.5%   
Avg P/E ratio x33.323.9 139.4%  
P/CF ratio (eoy) x26.517.0 155.7%  
Price / Book Value ratio x3.93.4 113.6%  
Dividend payout %25.12.9 863.0%   
Avg Mkt Cap Rs m4,127164,440 2.5%   
No. of employees `0001.79.2 18.5%   
Total wages/salary Rs m6077,470 8.1%   
Avg. sales/employee Rs Th2,436.74,213.9 57.8%   
Avg. wages/employee Rs Th355.2809.0 43.9%   
Avg. net profit/employee Rs Th72.5745.2 9.7%   
INCOME DATA
Net Sales Rs m4,16238,911 10.7%  
Other income Rs m611,571 3.9%   
Total revenues Rs m4,22340,482 10.4%   
Gross profit Rs m1979,795 2.0%  
Depreciation Rs m322,772 1.1%   
Interest Rs m30260 11.5%   
Profit before tax Rs m1978,334 2.4%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m731,616 4.5%   
Profit after tax Rs m1246,881 1.8%  
Gross profit margin %4.725.2 18.8%  
Effective tax rate %37.019.4 190.9%   
Net profit margin %3.017.7 16.8%  
BALANCE SHEET DATA
Current assets Rs m1,62940,477 4.0%   
Current liabilities Rs m1,05816,783 6.3%   
Net working cap to sales %13.760.9 22.5%  
Current ratio x1.52.4 63.8%  
Inventory Days Days3060 50.0%  
Debtors Days Days3483 40.5%  
Net fixed assets Rs m55645,073 1.2%   
Share capital Rs m781,000 7.8%   
"Free" reserves Rs m87847,377 1.9%   
Net worth Rs m1,06948,377 2.2%   
Long term debt Rs m15921,082 0.8%   
Total assets Rs m2,39993,942 2.6%  
Interest coverage x7.633.1 22.9%   
Debt to equity ratio x0.10.4 34.1%  
Sales to assets ratio x1.70.4 418.8%   
Return on assets %6.47.6 84.3%  
Return on equity %11.614.2 81.5%  
Return on capital %18.512.6 146.4%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3312,988 0.3%   
Fx outflow Rs m637,899 0.8%   
Net fx Rs m-305,089 -0.6%   
CASH FLOW
From Operations Rs m1276,400 2.0%  
From Investments Rs m-146-4,985 2.9%  
From Financial Activity Rs m22-1,775 -1.2%  
Net Cashflow Rs m3-473 -0.5%  

Share Holding

Indian Promoters % 65.4 40.4 161.9%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 3.7 8.4 44.0%  
FIIs % 5.2 10.7 48.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 19.9 129.6%  
Shareholders   12,723 109,995 11.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   TORRENT PHARMA  NATCO PHARMA  AJANTA PHARMA  SANOFI INDIA  ALEMBIC PHARMA  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Firm; Software & FMCG Stocks Gain(Closing)

Indian share markets finished the trading session well above the dotted line, snapping a three-day falling streak amid firm Asian markets.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 21, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS